Prophylactic percutaneous left ventricular assist device in pregnancy

Area of Science:

• Cardiology
• Maternal-Fetal Medicine
• Critical Care

Background:

• Pregnancy-associated cardiomyopathy presents unique management challenges, often earlier than traditionally defined peripartum cardiomyopathy.
• Optimal timing for delivery and therapeutic interventions remain poorly defined for these high-risk pregnancies.

Observation:

• A 30-year-old primigravid at 26 weeks gestation presented with ventricular tachycardia, biventricular cardiac failure, and severe mitral regurgitation.
• The patient was medically stabilized for two weeks, showing modest improvement before delivery.

Findings:

• Due to critical cardiac decompensation and pulmonary edema, a percutaneous left ventricular assist device (pLVAD) was utilized immediately prior to cesarean delivery.
• The patient received mechanical circulatory support for 36 hours, stabilizing hemodynamic changes post-delivery.

Implications:

• Percutaneous left ventricular assist devices represent a novel therapeutic option for managing acute hemodynamic instability in pregnancy-associated cardiomyopathy.
• This case highlights the potential of mechanical circulatory support in improving outcomes for parturients with severe, decompensated heart failure during pregnancy.